ProQR Therapeutics N.V. (PRQR) Earnings
ProQR Therapeutics N.V. is expected to report next earnings on August 6, 2026 (in NaN days), with a consensus EPS estimate of $-0.14. PRQR has beaten EPS estimates in 5 of its last 12 reported quarters (average surprise -20.3% over the last four).
Next earnings
Aug 6, 2026in NaN days
EPS est $-0.14 · Revenue est $5M
Track record
Beat EPS in 5 of 12 quarters
Avg surprise -20.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 12, 2026 | $-0.15 | $-0.15 | +0.0% | $2M | -54.7% |
| Mar 12, 2026 | $-0.10 | $-0.09 | +13.8% | $5M | -15.5% |
| Nov 6, 2025 | $-0.10 | $-0.12 | -20.0% | $3M | -44.2% |
| Aug 7, 2025 | $-0.08 | $-0.14 | -75.0% | $4M | -18.2% |
| May 8, 2025 | $-0.09 | $-0.11 | -22.2% | $5M | +3.1% |
| Mar 13, 2025 | $-0.10 | $-0.10 | +0.0% | $4M | -18.1% |
| Nov 7, 2024 | $-0.12 | $-0.11 | +8.3% | $4M | -39.8% |
| Aug 8, 2024 | $-0.12 | $-0.03 | +75.0% | $7M | -43.4% |
| May 9, 2024 | $-0.12 | $-0.10 | +16.7% | $5M | +70.5% |
| Mar 13, 2024 | $-0.08 | $-0.08 | +0.0% | $4M | -79.8% |
| Aug 3, 2023 | $-0.12 | $-0.11 | +8.3% | $1M | -23.1% |
| May 16, 2023 | $-0.12 | $-0.12 | +0.0% | $712124 | -49.9% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.